Please find attached unaudited standalone and consolidated Financial results for the quarter and half year ended September 30, 2026

Date: 06-11-2026 BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400001. Subject: Outcome of Board Meeting held on Friday, 06th November, 2026 Ref: Regulation 30 of the SEBI (LODR) Regulations, 2015 Dear Sir, Pursuant to Regulation 33 (3) of the SEBI (LODR) Regulations, 2015 read with Regulation 30 of SEBI (LODR) Regulations, 2015, it is hereby informed that the Board of Directors today i.e. Friday, 06th November, 2026 at their meeting transacted and approved the following business amongst others: 1. The Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended 30th September, 2026 along with the Limited Review Report; a copy of same is enclosed herewith as “Annexure-I”; 2. Subject to Shareholder’s Approval through Postal Ballot, the Company has proposed to increase the Authorised Share Capital of the Company from Rs. 7,00,00,000/- (Rupees Seven Crores) divided into 7,00,00,000 (Seven Crores) Equity Shares having face value of Re.1/- each to Rs.8,00,00,000/- (Rupees Eight Crores Only) divided into 8,00,00,000 (Eight Crores) Equity Shares having face value of Re. 1/- each, pursuant to said increase the Clause 5 of the Memorandum of Association will be altered accordingly; Existing Authorised Share Capital New Authorised Share Capital Rs.7,00,00,000/- (Rupees Seven Crores Only) Rs.8,00,00,000/- (Rupees Eight Crores divided into 7,00,00,000 (Seven Crores) Only) divided into 8,00,00,000 (Eight Equity Shares having face value of Re. 1/- Crores) Equity Shares having face value each. of Re. 1/- each. 3. Subject to shareholders approval and other statutory and regulatory approvals, as applicable, raising of funds by way of issuing and allotting up to 62,50,000 (Sixty Two Lakhs Fifty Thousand) Equity Shares on Preferential Basis to identified Promoters and Non-Promoters of the Company in accordance with the provisions of Chapter V of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 [‘SEBI (ICDR) Regulations, 2018’]. The requisite details are enclosed herewith as “Annexure – II”. Time of Commencement: 3.30 P.M Time of Conclusion: 5:40 P.M Kindly take the above on your records. Thanking You. For and on behalf of the Board of Directors of United Van Der Horst Limited Kalpesh Kantilal Shah Chief Financial Officer Annexure - I Independent Auditor’s Review Report on the Unaudited Standalone Financial Results of United Van Der Horst Ltd. for the Quarter and Half Year ended 30/09/2026, pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended The Board of Directors United Van Der Horst Ltd. 1. We have reviewed the accompanying Statement of Unaudited Standalone Financial Results of United Van Der Horst Ltd. (“the Company”) for the quarter and half year ended 30/09/2026 (herein after referred to as “the Statement”), being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“the Listing Regulations”). We have stamped and initialled the Statement for identification purpose only. 2. This Statement, which is the responsibility of the Company’s management and approved by the Company’s Board of Directors, in its meeting held on 06/11/2026, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 – ‘Interim Financial Reporting’ prescribed under section 133 of the Companies Act, 2013, as amended (“the ‘Act”), read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, ‘Review of Interim Financial Information Performed by the Independent Auditor of the Entity’ issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free from material misstatement. A review is limited primarily to inquiries of company personnel, primarily responsible for financial and accounting matters, and analytical procedures applied to financial data and thus provides less assurance than an audit conducted in accordance with the Standards on Auditing specified under Section 143(10) of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. We have not performed an audit and accordingly, we do not express an audit opinion. 4. Based on our review conducted and procedures performed as stated in para 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with recognition and measurement principles laid down in the Indian Accounting Standards prescribed under Section 133 of the Companies Act, 2013, as amended, read with relevant rules issued there-under and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the Listing Regulations, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. For C K S P AND CO LLP Chartered Accountants FRN – 131228W / W100044 Dhananajay Jaiswal Partner M.No. 187686 UDIN: 26187686WSTURY8779 Place: Mumbai Date: 06/11/2026 UNITED VAN DER HORST LTD. STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED 30TH SEPT, 2026 (Rs. in Lakhs, except for per share data) Particulars Quarter Ended Half Year Ended Year Ended 30-Sep-26 30-Jun-26 30-Sep-25 30-Sep-26 30-Sep-25 31-Mar-26 Unaudited Unaudited Unaudited Unaudited Unaudited Audited 1 Income a. Revenue from operations 1,001.32 915.02 864.58 1,916.34 1,773.89 3,194.22 b. Other Income 9.23 5.72 17.82 14.95 32.99 87.32 Total Income 1,010.55 920.74 882.40 1,931.29 1,806.88 3,281.54 2 Expenses a. Cost of materials consumed 441.86 355.08 340.49 796.94 688.57 1,290.87 b. Changes in inventories of work-in-progress (22.79) 14.76 (97.76) (8.03) (142.23) (285.69) c. Employee benefits expense 47.46 45.07 40.58 92.53 80.67 183.29 d. Finance costs 77.80 63.56 57.25 141.36 114.63 229.95 e. Depreciation and amortization expense 73.78 70.82 71.43 144.60 140.24 271.11 f. Other expenses 235.91 218.66 186.05 454.57 321.68 803.09 Total Expenses 854.02 767.95 598.04 1,621.97 1,203.56 2,492.62 3 Profit / (Loss) before exceptional and tax (1-2) 156.53 152.79 284.36 309.32 603.32 788.92 4 Exceptional items - - - - - - 5 Profit / (Loss) before tax (3-4) 156.53 152.79 284.36 309.32 603.32 788.92 6 Tax expense a. Current Tax 34.49 35.37 67.72 69.86 141.86 170.98 b. Deferred Tax Charge/ (Credit) (4.36) 5.00 1.37 0.64 9.63 26.45 c. (Excess) / Short Provision of earlier year - - 15.74 - 48.21 69.64 7 Profit / (Loss) for the period (5-6) 126.40 112.42 199.53 238.82 403.62 521.85 8 Other comprehensive income (net of tax) Items that will not be reclassified to Profit / (Loss) 0.84 (0.03) 0.40 0.81 0.16 (0.74) 9 Total comprehensive income for the period (7+8) 127.24 112.39 199.93 239.63 403.78 521.11 10 Paid-up Equity Share Capital (face value Re.1/-) 689.44 689.44 689.44 689.44 689.44 689.44 11 Reserves excluding Revaluation reserves 1,958.84 12 Earning Per Share (EPS) on (face value of Re.1/-)* Basic (Rs.) 0.18 0.16 0.29 0.35 0.59 0.76 Diluted (Rs.) 0.18 0.16 0.29 0.35 0.59 0.76  Earnings per equity share for the quarter and half year ended are not annualised. The basic and diluted earnings per share for the prior periods have been restated to give effect to the equity share split effecti [Showing first 8,000 characters — download PDF for full document]